| 000 | 01638 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514071707.0 | ||
| 264 | 0 | _c20040115 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0918-6158 | ||
| 024 | 7 |
_a10.1248/bpb.26.780 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Binbin | |
| 245 | 0 | 0 |
_aGenistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _cJun 2003 |
||
| 300 |
_a780-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Resorption _xpathology |
| 650 | 0 | 4 |
_aEpithelium _xdrug effects |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFemur _xcytology |
| 650 | 0 | 4 |
_aGenistein _xadministration & dosage |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred ICR |
| 650 | 0 | 4 | _aMicroscopy, Confocal |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 | _aOvariectomy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTibia _xcytology |
| 650 | 0 | 4 |
_aUterus _xdrug effects |
| 700 | 1 | _aYu, Shifeng | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 26 _gno. 6 _gp. 780-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.26.780 _zAvailable from publisher's website |
| 999 |
_c12592385 _d12592385 |
||